10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has reached a settlement agreement with Bruker Corporation, successfully resolving all ...

10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February ...

10x Genomics Navigates Revenue Dip with New Launches 10x Genomics reports Q3 EPS (30c), consensus (34c) 10x Genomics lowers FY24 revenue view to $595M-$605M from $640M-$660M ...

In this cross-journal collection, we invite submissions on medicinal plants genomics with the focuses on genome assembly, population genetics, comparative ...

Genomics plc is a global leader in PRS-powered technologies and approaches and has developed extensive genetic databases and algorithms to understand the genetic component of diseases.

Within Brown Hall on RIT’s campus, newly renovated lab spaces house state-of-the-art equipment allowing for essential research. One such space is the genomics lab, where Elle Barnes, assistant ...

RIT’s genomics research capabilities have evolved significantly over the past year. The university has invested heavily in revamping and equipping its Genomics Research Lab Cluster. The overhauled ...

10x Genomics defeats startup's attempt to end gene-analysis patent case By Blake Brittain September 14, 202311:33 AM PDTUpdated September 15, 2023 ...

Ultima Genomics claims $100 full genome sequencing after stealth $600M raise Devin Coldewey 2:25 PM PDT · May 31, 2022 ...

" 10x Genomics' single-cell and spatial technologies are trusted by leading biotechs and the top 20 global pharmaceutical companies to provide actionable insights at every stage of drug discovery ...

The U.K. Government-owned Genomics England was established in 2012, as part of a landmark project to sequence 100,000 whole genomes from NHS patients. It now runs the National Genomic Research ...